XML 33 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021   124,303,083      
Beginning balance at Dec. 31, 2021 $ 363,576 $ 12 $ 444,388 $ (184) $ (80,640)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   211,309      
Issuance of common stock upon exercise of vested stock options 188   188    
Issuance of common stock under employee stock purchase plan (in shares)   48,353      
Issuance of common stock under employee stock purchase plan 153   153    
Stock-based compensation expense 4,677   4,677    
Other comprehensive loss (584)     (584)  
Net loss (30,452)       (30,452)
Ending balance (in shares) at Jun. 30, 2022   124,562,745      
Ending balance at Jun. 30, 2022 337,558 $ 12 449,406 (768) (111,092)
Beginning balance (in shares) at Mar. 31, 2022   124,456,653      
Beginning balance at Mar. 31, 2022 349,709 $ 12 446,654 (554) (96,403)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   57,739      
Issuance of common stock upon exercise of vested stock options 32   32    
Issuance of common stock under employee stock purchase plan (in shares)   48,353      
Issuance of common stock under employee stock purchase plan 153   153    
Stock-based compensation expense 2,567   2,567    
Other comprehensive loss (214)     (214)  
Net loss (14,689)       (14,689)
Ending balance (in shares) at Jun. 30, 2022   124,562,745      
Ending balance at Jun. 30, 2022 337,558 $ 12 449,406 (768) (111,092)
Beginning balance (in shares) at Dec. 31, 2022   124,865,485      
Beginning balance at Dec. 31, 2022 $ 314,924 $ 12 455,330 (1,854) (138,564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares) 5,907 5,907      
Issuance of common stock upon exercise of vested stock options $ 7   7    
Issuance of common stock under employee stock purchase plan (in shares)   59,507      
Issuance of common stock under employee stock purchase plan 92   92    
Stock-based compensation expense 5,958   5,958    
Other comprehensive loss (535)     (535)  
Net loss (30,773)       (30,773)
Ending balance (in shares) at Jun. 30, 2023   124,930,899      
Ending balance at Jun. 30, 2023 289,673 $ 12 461,387 (2,389) (169,337)
Beginning balance (in shares) at Mar. 31, 2023   124,866,392      
Beginning balance at Mar. 31, 2023 303,715 $ 12 458,191 (959) (153,529)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   5,000      
Issuance of common stock upon exercise of vested stock options 6   6    
Issuance of common stock under employee stock purchase plan (in shares)   59,507      
Issuance of common stock under employee stock purchase plan 92   92    
Stock-based compensation expense 3,098   3,098    
Other comprehensive loss (1,430)     (1,430)  
Net loss (15,808)       (15,808)
Ending balance (in shares) at Jun. 30, 2023   124,930,899      
Ending balance at Jun. 30, 2023 $ 289,673 $ 12 $ 461,387 $ (2,389) $ (169,337)